论文部分内容阅读
中药在我国应用已有数千年历史,是我国珍贵的科学文化遗产之一,具有丰富的内涵及临床医疗保健价值。他的独特的理论和卓越的疗效,不仅为华裔、亚裔的人群所接受,也逐渐为西方发达国家的民众所接受。然而另一方面,由于其传统性,在制造工艺、服用方法、药物剂型、质量标准诸方面尚未能与国际药学要求接轨,因此了解国际新药研制及开发水准,已是当务之急。鉴此,最近国家中医药管理局
Traditional Chinese medicine has been used in China for thousands of years and is one of China’s precious scientific cultural heritages. It has rich connotations and clinical health care values. His unique theory and excellent efficacy were not only accepted by the Chinese and Asian-Americans, but also gradually accepted by the Western developed countries. On the other hand, due to its traditional nature, it has not been able to meet international pharmaceutical requirements in terms of manufacturing processes, methods of administration, drug formulations, and quality standards. Therefore, it is imperative to understand the development and development standards of international new drugs. In view of this, recently the State Administration of Traditional Chinese Medicine